Fei Chen
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 8
- RNA modifications and cancer 8
- RNA Research and Splicing 5
- Renal and related cancers 5
- Oncology 41
- Cancer Cells and Metastasis 10
- Pancreatic and Hepatic Oncology Research 7
- Cancer-related Molecular Pathways 5
- Co-authors
- Hongjuan Cui (5 shared papers)Zhen Dong (3 shared papers)Liqun Yang (1 shared paper)Wen Peng (1 shared paper)Jiayi Zhang (1 shared paper)Gaichao Zhao (1 shared paper)Guanghui Zhang (1 shared paper)Pengfei Shi (1 shared paper)
- Journals
- Oncotarget (6 papers)Cancer Research (4 papers)Seminars in Cancer Biology (4 papers)PLoS ONE (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Fei Chen
90 papers receiving 4.9k citations
Fei Chen's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 1.2k
- Oncology 1.9k
- Immunology 932
- Molecular Biology 2.5k
- Cell Biology 286
Countries citing papers authored by Fei Chen
This map shows the geographic impact of Fei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Chen more than expected).
Fields of papers citing papers by Fei Chen
This network shows the impact of papers produced by Fei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Chen. The network helps show where Fei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting cancer stem cell pathways for cancer therapy Hit paper breakdown → | 2020 | 1406 |
| 2 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness Hit paper breakdown → | 2018 | 946 |
| 3 | A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis Hit paper breakdown → | 2014 | 617 |
| 4 | 2012 | 169 | |
| 5 | 2019 | 132 | |
| 6 | 1999 | 89 | |
| 7 | 2011 | 88 | |
| 8 | 2021 | 85 | |
| 9 | 2009 | 76 | |
| 10 | 2005 | 63 | |
| 11 | 2019 | 58 | |
| 12 | 2016 | 55 | |
| 13 | 2012 | 53 | |
| 14 | 2013 | 50 | |
| 15 | 2004 | 46 | |
| 16 | 2013 | 42 | |
| 17 | 2013 | 40 | |
| 18 | 2022 | 39 | |
| 19 | 1999 | 39 | |
| 20 | 2019 | 37 |
About Fei Chen
Fei Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 94 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), RNA Research and Splicing (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer-related Molecular Pathways (5 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.9k citations), Immunology (932 citations), Molecular Biology (2.5k citations) and Cell Biology (286 citations). Fei Chen has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Hongjuan Cui, Zhen Dong, Liqun Yang, Wen Peng, Jiayi Zhang, Gaichao Zhao, Guanghui Zhang, Pengfei Shi, Jie Xu and Xiaowen Wang. Their work appears in journals such as Oncotarget, Cancer Research, Seminars in Cancer Biology, PLoS ONE and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.